id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-340415-6fte7krp	Thevarajan, Irani	Clinical presentation and management of COVID‐19	2020-07-17		.txt	text/plain	4287	244	43	In the face of high health care demand during the peak of a pandemic, safe management of low risk patients in the community will likely be essential to preserve hospital capacity for the more severely ill. This position is endorsed by the Australasian Society for Infectious Diseases interim guidelines for the clinical management of COVID-19 in adults, 20 guidelines for the clinical care of people with COVID-19, 19 which state that even where conditional recommendations for use of disease modifying agents are made, whenever possible these should be administered in the context of randomised trials with appropriate ethical approval. 37, 38 However, given the current lack of evidence of clinical benefit and reports of significant limitations of supply of hydroxychloroquine for patients with rheumatological conditions, in March 2020, the Pharmaceutical Society of Australia and the Australasian Society for Infectious Diseases called for immediate cessation of prescribing and dispensing of hydroxychloroquine for indications relating to COVID-19, outside use in approved clinical trials. Specific antiviral therapy in the clinical management of acute respiratory infection with SARS-CoV-2 (COVID-19).	./cache/cord-340415-6fte7krp.txt	./txt/cord-340415-6fte7krp.txt